Login to Your Account



Pharma: Other News To Note


Tuesday, January 8, 2013
• Merck & Co. Inc., of Whitehouse Station, N.J., said its resubmitted new drug application for sugammadex sodium injection was accepted for review by the FDA. Merck expects the agency's review to be completed in the first half of this year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription